Published in TB and Outbreaks Week, December 27th, 2005
The attenuation refers to a genetic modification that is intended to improve the vaccine's safety.
The purpose of the studies was to compare the safety of VaxGen's attenuated vaccine candidate, LC16m8, with that of the unattenuated Lister strain of vaccinia. Lister vaccine, the parent strain from which LC16m8 is derived, was used in the World...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.